For decades, the cultural narrative surrounding eating disorders has remained stubbornly narrow: a thin, young, white female struggling to restrict her caloric intake. This archetype, while valid, has inadvertently created a blind spot in clinical practice, leaving millions of men and boys to suffer in the shadows. With men accounting for approximately one-third of the population struggling with eating disorders in the United States, the medical community is facing a reckoning. Experts like Dr. Jason Nagata are now spearheading a movement to reform how we classify, identify, and treat "muscle dysmorphia"—a condition that, despite its prevalence, remains poorly understood and chronically misdiagnosed.
The Hidden Crisis: Facts and Prevalence
The statistics are as sobering as they are ignored. While eating disorders typically emerge during adolescence, research suggests that as many as 14% of American men will experience an eating disorder by the age of 40. Perhaps most alarming is the data suggesting that men may be more likely to die from these conditions than women, often due to the delay in seeking help and the clinical failure to recognize symptoms that do not align with traditional, weight-loss-centric presentations.
At the heart of this struggle is muscle dysmorphia, a condition often colloquially dubbed "bigorexia" or "reverse anorexia." Unlike traditional anorexia, where the primary drive is thinness, muscle dysmorphia is defined by a pathological, hyper-fixated pursuit of muscularity. Patients with this condition may be objectively athletic or muscular, yet they perceive themselves as perpetually scrawny or underdeveloped. This obsession frequently manifests through extreme dietary control—cutting carbohydrates or fats, protein-loading, and "biohacking"—coupled with excessive exercise and, in some cases, the use of performance-enhancing substances.
Chronology of a Diagnostic Dilemma
The inclusion of muscle dysmorphia in the Diagnostic and Statistical Manual of Mental Disorders (DSM) thirteen years ago was a milestone for mental health advocacy. However, the current classification—nestled under "obsessive-compulsive and related disorders"—has become a bottleneck for treatment.
The Problem of Mutual Exclusivity
To meet the current DSM criteria for muscle dysmorphia, a patient must exhibit a preoccupation with muscularity, repetitive checking behaviors (such as mirror-gazing or frequent weighing), and significant social or occupational impairment. Crucially, the diagnostic criteria stipulate that the condition cannot be "better explained" by an eating disorder.
This creates a rigid "either/or" scenario. If a patient displays the classic signs of an eating disorder—such as the restrictive eating patterns often used to attain a specific muscular aesthetic—they are technically disqualified from a muscle dysmorphia diagnosis. This binary, according to Dr. Jason Nagata, an associate professor of pediatrics at the University of California, San Francisco (UCSF), is scientifically and clinically flawed.
"You can’t really separate exercise and nutrition; they go hand in hand," Dr. Nagata explains. "Some people have an eating disorder, or disordered eating, because they’re trying to become muscular, and there is no specific eating disorder diagnosis that captures muscularity concerns."
The Clinical Reality: When "Unspecified" Becomes the Default
In the sterile hallways of eating disorder treatment centers, the impact of this classification failure is palpable. Dr. Nagata, who serves as an eating disorders hospitalist at UCSF Benioff Children’s Hospital, notes that his facility has seen a surge in male patients in recent years. Yet, because no diagnosis perfectly captures their experience, they are frequently labeled with "Unspecified Feeding and Eating Disorder" (UFED).
The UFED label is a catch-all that fails to address the unique psychological drivers of muscle dysmorphia. When these men arrive in group therapy settings, they are often surrounded by patients focused on weight loss, which can exacerbate their feelings of isolation. "It’s already an isolating experience," says Dr. Nagata. "Not being able to relate to the people around you in a treatment setting only deepens that sense of alienation."
Supporting Data and the Insurance Barrier
The diagnostic confusion extends far beyond the therapy room; it has tangible consequences for insurance coverage and professional liability.
Under the current DSM-5 framework, providers are discouraged from coding for both muscle dysmorphia and an eating disorder simultaneously. This puts clinicians in an impossible position: to secure the insurance coverage a patient needs, they may have to code for both, potentially risking accusations of misdiagnosis or insurance audits. Conversely, if they adhere strictly to the manual, they may be forced to provide an incomplete or inaccurate diagnosis that fails to capture the full spectrum of the patient’s illness.
Official Responses and Internal Debate
The proposal to reclassify muscle dysmorphia as an eating disorder in the upcoming sixth edition of the DSM is not without its detractors. Within the psychiatric field, a robust debate is underway.
Some experts argue that the current classification is accurate and that the existing flexibility—allowing a dual diagnosis or combining the disorder with other comorbidities—is sufficient. They contend that shifting the diagnostic home of muscle dysmorphia might obscure the obsessive-compulsive features that are central to the disorder.
However, proponents of reclassification argue that the current system is archaic. They point to the "tip of the iceberg" phenomenon: because we lack a specific diagnostic category, most men on the spectrum of muscle dysmorphia never receive a formal diagnosis until their condition is advanced, leading to a significant undercount in national health surveys and a lack of targeted funding for research.
Implications: A Path Toward Inclusive Care
If the psychiatric community moves to reclassify muscle dysmorphia, the implications for public health could be profound. A formal, recognized diagnosis would likely lead to:
- Improved Insurance Coverage: Standardized coding would provide a clearer path for medical necessity, ensuring patients can access long-term care without fear of administrative rejection.
- Specialized Training: With a clear diagnostic label, medical providers—from pediatricians to general practitioners—could be trained to recognize the specific warning signs of muscle-focused eating disorders, rather than relying on questions centered solely on weight loss.
- Increased Research Funding: Currently, the "unspecified" nature of these diagnoses makes it difficult to secure grants for longitudinal studies. Formalization would allow for a more rigorous, data-driven approach to developing evidence-based treatments.
- Destigmatization: Perhaps most importantly, reclassification would validate the experiences of millions of men who feel excluded from the conversation about eating disorders. By acknowledging that these conditions cross all demographics—regardless of gender, race, or socioeconomic status—the medical field can begin to dismantle the "double stigma" that prevents men from seeking help.
Conclusion: Expanding the Horizon
The journey toward better care for men with eating disorders requires more than just a change in a manual; it requires a paradigm shift in how we perceive the body. Dr. Nagata’s advocacy highlights a critical need to update our screening tools. By incorporating questions about supplement use, performance-enhancing substances, and compulsive exercise into routine checkups, the medical community can begin to catch these issues before they reach a crisis point.
As the field looks toward the next iteration of the DSM, the goal is clear: the diagnostic framework must evolve to reflect the reality of the patient, not the other way around. By broadening the definition of eating disorders, we can ensure that every individual—whether they are struggling to shrink their body or obsessively trying to grow it—has the opportunity to find the help, visibility, and healing they deserve. The silence that has surrounded this issue for too long is finally breaking; it is time for the clinical guidelines to follow suit.
